Latest
Clair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable EraClair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable Era|Orthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI AgentsOrthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI Agents|Tugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era ProblemTugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era Problem|fomo Raises $75M Series B as Social Trading Moves Mainstreamfomo Raises $75M Series B as Social Trading Moves Mainstream|DropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug DiscoveryDropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug Discovery|HistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the MainstreamHistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the Mainstream|Upscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats UpUpscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats Up|Nura Bio Raises $73.8M Series B to Advance SARM1 NeuroprotectionNura Bio Raises $73.8M Series B to Advance SARM1 Neuroprotection|Vedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine TherapiesVedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine Therapies|Cargofy Raises $11M Series A as AI Workers Move From Demo to Deployment in Freight LogisticsCargofy Raises $11M Series A as AI Workers Move From Demo to Deployment in Freight Logistics|Clair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable EraClair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable Era|Orthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI AgentsOrthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI Agents|Tugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era ProblemTugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era Problem|fomo Raises $75M Series B as Social Trading Moves Mainstreamfomo Raises $75M Series B as Social Trading Moves Mainstream|DropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug DiscoveryDropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug Discovery|HistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the MainstreamHistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the Mainstream|Upscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats UpUpscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats Up|Nura Bio Raises $73.8M Series B to Advance SARM1 NeuroprotectionNura Bio Raises $73.8M Series B to Advance SARM1 Neuroprotection|Vedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine TherapiesVedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine Therapies|Cargofy Raises $11M Series A as AI Workers Move From Demo to Deployment in Freight LogisticsCargofy Raises $11M Series A as AI Workers Move From Demo to Deployment in Freight Logistics
Back to articles
•

Gyde Secures $60M for AI-Powered Brokerage Platform in Austin, TX

January 28, 2026. Austin, Texas. A $60 million launch round hits the wire and it is not another AI fairy tale hunting a problem. It is Gyde, an AI-native insurance brokerage platform built by people who have lived inside the grind and decided the grind was the problem. Will Johnson and Sam Wiener did not wake up one morning with a pitch deck and a buzzword. They came out of Oscar Health watching smart agencies drown in admin while clients waited on hold for answers that mattered to their lives.

Gyde plants its flag where healthcare, insurance, and wealth advice collide, a $5 trillion value chain powered by brokers who do the real explaining when stakes are high. The company is headquartered in Austin with an office in New York City, but the posture is national and the ambition is structural. Gyde does not erase agencies. It acquires them, keeps their identity intact, preserves ownership economics, and then injects technology that actually works when the phone rings at 9 p.m.

Lightspeed Venture Partners led the $60 million seed with Dr. Brenton Fargnoli, Isaac Kim, and Amish Desai leaning in early. Optum Ventures joined through Laura Veroneau, alongside Jonathan Crystal from Crystal Venture Partners, Sean Doolan of Virtue, Geoff Winegar of MVP Ventures, and multiple endowments that rarely chase noise. Eight months from founding to full institutional backing tells you this was underwritten on scars, not slides.

The tech stack reads like a broker’s wish list written by engineers who hate wasted motion. GydeOS runs renewals, onboarding, scheduling, service routing, and coverage gap analysis. Gia, the always-on AI assistant, handles voice and SMS, summarizes conversations, flags missed coverage, and keeps everything compliant with HIPAA, CMS, and TCPA because shortcuts get people hurt in this business. The stated target is automating 25 percent of broker workflows while keeping humans in the moments that count.

Will Johnson brings a decade inside Oscar Health, from sales to P&L leadership, and Sam Wiener carries growth and operations experience from Oscar, Spark Advisors, and Zocdoc. Around them is a team pulled from Stripe, Tesla, and healthcare operators who know regulation is not a suggestion. The model is acquisition-first, owner-aligned, and unapologetically long-term.

Gyde is betting that brokers do not need replacement. They need leverage. And when capital, code, and lived experience line up like this, the question is not whether agencies will pay attention. It is how fast the guides become impossible to ignore.

Related Articles

More from Jesse Landry

Trending

View all posts